Emerging Market Rx Growth Heating Up As Mature Markets Cool, IMS Says
This article was originally published in PharmAsia News
Executive Summary
The improving regulatory environment in emerging international markets is helping to drive global pharmaceutical growth despite a slowdown within mature markets
You may also be interested in...
Global Generics Market Shows Significant Decline Despite Higher Volumes and Double Digit Growth In Japan, Europe – IMS Health
MUMBAI - Despite a robust increase in volumes, the global generics prescription market has grown by just 3.6 percent, a nearly 7 percent drop from the 11.4 percent growth seen in 2007, a report by IMS Health, the global pharmaceutical and health care intelligence provider said
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).